SCHOTT Type I plus®

Select product

Please choose a product variant:

$675.00 /Tray

Quantity

Need any help or a quote?

Coated glass vials for injectable drugs

With a silicon dioxide coating on the inside surface, SCHOTT Type I plus® vials has set the standard for barrier properties, which greatly reduces drug-container interaction. Since protein adsorption and leaching from glass packaging can compromise the shelf life of sensitive drugs, these vials are the ideal packaging solution.

Our SCHOTT Type I plus® vials also offer minimal adsorption of radioactive molecules, as well as 100% camera inspection of a large number of dimensional and cosmetic specifications, ensuring very low levels of defect. This makes them ideal for a range of applications, including radioactive diagnostics, proteins and enzymes.

Properties

Increased shelf life for highly sensitive drug formulations.
Minimal protein adsorption in liquid formulations, both before and after lyophilization.
Minimal adsorption of radioactive molecules.
Portfolio range: ISO 2 R - 100 R
Product manufactured according to relevant international norms and standards
Product registered at Regulatory Authorities as e.g. US FDA and China NMPA (and available for Pharmaceutical Registration Applications)

Chemical Resistance

• The inside silicon dioxide coating of SCHOTT Type I plus® vials provides an effective barrier to ion leaching (sodium, calcium, boron, silicon and aluminum).
• For production control, the standard Hydrolytic Resistance test is added by a special Type I plus® testing as a release criteria, SCHOTT specifies a limit value of 0.17 μg/ml Na after 6h autoclaving at 121 °C with 0.1 M HCl for all sizes.

Dimensions & Cosmetics

• Tight geometric tolerances thanks to 100% camera inspection of dimensional and cosmetic parameters along the process line.
• Strict AQLs, with cosmetic defects a key part of the product specification. Any containers with critical defects are classified as "not allowed in the lot".

Possible Applications

Enzymes and sensitive formulations
Since no metal ions can be leached from the glass, the reactivity of enzymes and sensitive formulations is unaffected.
Radioactive diagnostics
Less adsorption of radioactive molecules results in a reduction of residual radioactivity.
Proteins
The inner silicon dioxide coating of SCHOTT Type I plus® vials results in reduced adsorption of proteins.
Pure substances
As the silicon dioxide coating is chemically inert, highly pure substances are preserved over long stocking periods.
WFI and alkali-sensitive products
Unbuffered reagents such as water for injection are better protected against pH shifts.

Advantages

Increased shelf-life stability for sensitive drug formulations
Minimized adsorption of proteins in liquid formulations – also prior to lyophilization
Minimized adsorption of radioactive molecules

Brochure

SCHOTT Case Study - Storage of Highly Sensitive Drugs

SCHOTT Pharma Online Shop.

Our Online Shop provides an easy and fast access to small volume and high quality pharmaceutical packaging solutions. With standardized and pre-tested products we ensure fast delivery times. Our customer care helps you in case you need a product recommendation to safely package your drug.

Open at all times. Quality at all times.